Baopu Asset Management
3
15M
2
0.38
0.33
1
- Areas of investment
Summary
In 2015 was created Baopu Asset Management, which is appeared as VC. The fund was located in Asia if to be more exact in China. The main office of represented VC is situated in the Shanghai.
The common things for fund are deals in the range of 10 - 50 millions dollars. When the investment is from Baopu Asset Management the average startup value is 100-500 millions dollars. The fund is generally included in less than 2 deals every year. The top amount of exits for fund were in 2016. The important activity for fund was in 2017.
The standard case for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Tunlan Investment, Jinjiang International.
Besides, a startup needs to be aged 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most successful fund investment fields, there are Manufacturing, Electronics. Among the most popular portfolio startups of the fund, we may highlight Canaan Creative.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Exits
- 1
- Rounds per year
- 0.38
- Follow on index
- 0.33
- Investments by industry
- Health Care (2)
- Clinical Trials (2)
- Biotechnology (2)
- Medical (2)
- Manufacturing (1) Show 2 more
- Investments by region
-
- China (3)
- Peak activity year
- 2021
- Number of Unicorns
- 1
- Number of Decacorns
- 1
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 500M
- Group Appearance index
- 1.00
- Strategy success index
- 0.43
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Sumgen Biotech | 07 Dec 2021 | Biotechnology, Health Care, Medical, Clinical Trials | Early Stage Venture | Zhejiang, Shangcheng District, China |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.